Skip to main content
Clinical Trials/NCT04719403
NCT04719403
Completed
Not Applicable

Determining the Feasibility, Acceptability, and Potential Effectiveness of Sharing Video Recordings of Multidisciplinary ALS Clinics With Patients and Their Caregivers

Dartmouth-Hitchcock Medical Center1 site in 1 country79 target enrollmentMay 12, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amyotrophic Lateral Sclerosis
Sponsor
Dartmouth-Hitchcock Medical Center
Enrollment
79
Locations
1
Primary Endpoint
Patient Enrollment (Feasibility)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Our objective in the proposed project is to: (a) operationalize and determine the feasibility and acceptability of a trial where clinic multi-disciplinary clinic (MDC) visits are audio/video recorded and shared with patients with ALS and their caregivers; (b) gather preliminary data examining the impact of routinely adding audio/video recordings of clinic visits to UC on self-management ability and other behavioral, health and health services outcomes at baseline (T0) and other regular interviews from enrollment (T1= 1 Week, T2= 3 Months); and (c) identify factors pertinent to the acceptability of our study protocol and the audio/video recording of visits.

Detailed Description

We will conduct a single-site, two-arm, parallel group, patient-randomized, controlled, pilot trial with 3-month follow up, to determine the feasibility, acceptability, and potential effectiveness of sharing audio/video recordings of multidisciplinary ALS clinics with patients and their caregivers. We will recruit 24 patients with ALS and their caregivers over a recruitment period of 1 year. We are primarily interested in determining the feasibility of the trial and acceptability of the audio/video intervention. We will also explore the impact on the patients' ability to self-manage their care as well as exploratory outcomes, at baseline (T0 = pre-visit), at T1 (1 week), and at T2 (3 months).

Registry
clinicaltrials.gov
Start Date
May 12, 2021
End Date
June 9, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Paul J. Barr

Associate Professor, The Dartmouth Institute for Health Policy and Clinical Practice

Dartmouth-Hitchcock Medical Center

Eligibility Criteria

Inclusion Criteria

  • diagnosed and primarily treated for Amyotrophic Lateral Sclerosis (ALS)
  • Aged 18 years or greater
  • Can communicate in English (verbally, on a computer, or with assistance)
  • Have email
  • Have internet access
  • Willing to have their multidisciplinary clinic visit audio/video recorded for a 3 month period

Exclusion Criteria

  • Those without the capacity to provide consent, either themselves or via proxy

Outcomes

Primary Outcomes

Patient Enrollment (Feasibility)

Time Frame: Study Completion, an average of 1 year

Meeting the targeted recruitment number and rate (two patients per month over a 12 month period)

Intervention Fidelity (Feasibility)

Time Frame: Three months

The proportion of ALS MDC (multidisciplinary clinic) patients in the intervention arm that received the VIDEO intervention with full adherence to a pre-defined protocol fidelity checklist. Any deviations will be documented.

Patient use of the Intervention (Acceptability)

Time Frame: Three months

The proportion of ALS MDC (multidisciplinary clinic) patients in the intervention arm who used the recording between the day of receipt and the three-month follow up

Secondary Outcomes

  • Change from baseline in Patient Satisfaction, as measured by the Patient Satisfaction Questionnaire-18 (PSQ-18)(Baseline, one week, three months)
  • Change from baseline in adherence to treatment, as measured by the Medical Outcomes Study - General Adherence(Baseline, one week, three months)
  • Change from baseline in adherence to medications, as measured by the Adherence to Refills and Medications Scale - 7 (ARMS-7)(Baseline, one week, three months)
  • Change from baseline in adherence to physical therapy, as measured by the Exercise Adherence Rating Scale (EARS)(Baseline, one week, three months)
  • Change from baseline in anxiety, as measured by the Generalized Anxiety Disorder - 7 (GAD-7)(Baseline, three months)
  • Change from baseline in functional status, as measured by the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS)(Baseline, one week, three months)
  • Change from baseline in depression, as measured by the Patient Health Questionnaire - 8 (PHQ-8)(Baseline, three months)
  • Level of Communication in the Visit, as measured by the Interpersonal Processes of Care (IPC)(One week)
  • Level of literacy, as measured by the Single Item Literacy Screener(Baseline)
  • Change in caregiver burden, as measured by the Burden Scale for Family Caregivers - Short (BSFC-s)(Baseline, one week, three months)
  • Change in caregiver preparedness, as measured by the Preparedness for Caregiving Scale(Baseline, one week, three months)
  • Change in self-efficacy, as measured by the Self Efficacy for Managing Chronic Disease scale(Baseline, one week, three months)
  • Feasibility of the Intervention, as measured by the Feasibility of Intervention Metric (FIM)(Three months from baseline)
  • Acceptability of the Intervention, as measured by the Acceptability of Intervention Metric (AIM)(Three months from baseline)

Study Sites (1)

Loading locations...

Similar Trials